Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 2

Study to Evaluate the REMEDY SPECTRUM GV IM Spacer Nail in the Treatment of Ankle-Related Infections

OsteoRemedies, LLC · with MCRA · NCT06428448

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 21+ · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 2
Target enrollment
60
US sites recruiting
3
Study start
February 1, 2026
Record last updated
May 19, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This study is being conducted to evaluate the safety and effectiveness of the REMEDY SPECTRUM IM Spacer Nail in the treatment of ankle-related infections. The study is expected to take approximately 18 months from first subject enrolled to the last follow-up visit. It will have a 12-month enrollment period and a 6-month follow-up. This study is a Prospective, multicenter, single-arm clinical trial. All subjects enrolled in this study will receive the REMEDY SPECTRUM IM Spacer Nail.

Being studied: REMEDY Spectrum IM Spacer Nail

Conditions: Periprosthetic Joint Infection

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Be ≥ 21 years of age
  • Have an ankle-related infection
  • Is skeletally mature, as evidenced by closed epiphyses.
  • Be able to give voluntary, written informed consent to participate and have signed an Informed Consent Form specific to this study
  • Be willing and able to comply with all study procedures including all pre-operative, post-operative requirements
  • If female and of child-bearing potential, must have a negative pregnancy test prior to the surgical procedure and no intention of becoming pregnant until study completion.

Exclusion Criteria

  • Infections that do not involve the ankle
  • Have a known immunodeficiency; including subjects who are receiving or have received immunosuppressants, immunostimulating agents or radiation therapy within 6 months prior to surgery
  • Affected limb is dysvascular
  • Where adequate soft-tissue coverage cannot be achieved
  • Have any mental or psychological disorder that would impair their ability to complete the study questionnaires
  • Are currently pregnant or breastfeeding, or planning to become pregnant or breastfeed any time during the course of the study
  • Are currently a prisoner
  • Have any medical condition or other circumstances, in the judgment of the Investigator, that might interfere with the ability to return for follow-up visits, including any systemic illness, neuromuscular, neurosensory, or musculoskeletal deficiency that would render the subject unable to perform appropriate post-operative activities.
  • History of vancomycin or gentamicin allergy
  • Are implanted with other antibiotic eluting products.

Recruiting US locations

  • University of Michigan Health - Sparrow Clinical Research Institute

    Lansing, MI 48190

    Site contact: Jennifer Boak · 517-364-5733 · Jennifer.Boak@UofMHealth.org

  • OrthoCarolina Research Institute

    Charlotte, NC 28207

    Site contact: Zachary Hutchko · 704-323-2556 · Zachery.Hutchko@orthocarolina.com

  • Duke University Medical Center

    Durham, NC 27710

    Site contact: Caroline Darragh · 919-613-3670 · caroline.darragh@duke.edu

Study contacts (from the official record)

  • Crystal Djaba · 470-736-7850 · cdjaba@mcra.com
  • Jacob Schafer · jschafer@mcra.com
Study to Evaluate the REMEDY SPECTRUM GV IM Spacer Nail in the… (NCT06428448) | Bored Studies